Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.26%
+5.06%
+11.88%
+1.85%
+0.63%
HIMS
Hims & Hers Health I
$51.40
Chart
29.14
59.18
26.56
15.83
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.26%
+5.06%
+11.88%
+1.85%
+0.63%
HIMS
Hims & Hers Health I
$51.40
Chart
29.14
59.18
26.56
15.83
HIMS Latest Headlines
Hims & Hers Stocks 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started. If short sellers were hoping for a flop from ) they may want to check their risk management settings. The telehealth disruptor dropped first-quarter earnings after the bell on Monday and instead of the crash shorts were counting on the market got a ish cocktail: strong guidance solid revenue growth and a headline-making partnership with Novo Nordisk A/S (NYSE:).Shares popped &. and they’.ve kept climbing
Today
Hims & Hers Health Stock Is Sliding Thursday: Whats Going On?. ) shares are falling Thursday morning after the company announced a proposed convertible senior notes offering.Hims &. Hers Health intends to use the proceeds to help accelerate global expansion through organic growth and strategic acquisitions as well as for general corporate purposes. The proceeds will also help support the company’.s technology team to expand its data pipeline develop AI tools and advance personalized trea
Today
Hims & Hers names former president and CTO at Cruise as Chief Technology Officer.
Today
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations.
Today
Hims & Hers shares fall on convertible notes offering.
Today
Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade).
Wed May 7, 2025
Hims & Hers: Strong Q1 Masks Problematic Long-Term Value Proposition.
Tue May 6, 2025
Looking At Hims & Hers Healths Recent Unusual Options Activity. Whales with a lot of money to spend have taken a noticeably ish stance on Looking at options history for Hims &. Hers Health (NYSE:) we detected 40 trades.If we consider the specifics of each trade it is accurate to state that 60% of the investors opened trades with ish expectations and 35% with bearish.From the overall spotted trades 5 are puts for a total amount of $450917 and 35 calls for a total amount of $2355941.Analyzing t
Tue May 6, 2025
Top 1% Stock Hims & Hers Health Dives On Lackluster Outlook. Hims stock crumbled Tuesday after the telehealth platform issued a lackluster outlook for the current three-month period.The post Top 1% Stock Hims &. Hers Health Dives On Lackluster Outlook appeared first on Investor'.s Business Daily.
Tue May 6, 2025
Pony AI Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?. These mid-cap stocks were the best performers in the last week. Are they in your portfolio?
Sun May 4, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HIMS Stock trends
HIMS Stock performance
HIMS Stock analysis
HIMS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Hims & Hers Health I (HIMS) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
